Sartorius Aktiengesellschaft (SRT.F)
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide.
176.40-0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+17.1%
The outlook
Sartorius Aktiengesellschaft currently reads as neutral based on buy — 1.8 avg of 9 analysts, below its 50- & 200-day averages, 50% of the way from its 52-week low to high, avg target +41% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 9 analysts
Price trendBelow its 50- & 200-day averages
52-week range50% of the way from its 52-week low to high
Price targetAvg target +41% vs current price
Analyst price target
~12-month · 9 analysts249.53average target+41.5% vs now
Now 176.40
Low 68.75High 445.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$12.18B
52-wk high
206.00
52-wk low
146.40
50-day avg
185.44
200-day avg
183.09
Trailing P/E
62.6